Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Post by Hiddensecretson Jan 08, 2021 2:56pm
174 Views
Post# 32255868

Biden making a MAJOR ERROR ON VACCINATION

Biden making a MAJOR ERROR ON VACCINATIONBiden has decided that he will give as many Americans as possible the first dose, while they deplete their stocks hoping that vaccine manufacturers can make 2nd dose in time.   This is very risky.

This is what Pfizer said of their vaccine:

Vaccine manufacturer contradicts government

Pfizer told a different story in a statement emailed to CBC.

Christina Antoniou, Pfizer Canada's Director of Corporate Affairs, said the company did a study to evaluate the vaccine's effectiveness in a two-dose schedule with the doses separated by 21 days.

"The safety and efficacy of the vaccine has not been evaluated on different dosing schedules as the majority of trial participants received the second dose within the window specified in the study design," Antoniou said.

"Although partial protection from the vaccine appears to begin as early as 12 days after the first dose, two doses of the vaccine are required to provide the maximum protection against the disease, a vaccine efficacy of 95 per cent," she said.

"There are no data to demonstrate that protection after the first dose is sustained after 21 days."

https://ca.yahoo.com/news/nurses-feel-betrayed-province-postpones-100000781.html
 

Biden will release nearly all available vaccine doses in break from Trump administration policy of holding back stock for second dose


<< Previous
Bullboard Posts
Next >>